FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309592785> ?p ?o ?g. }

• W4309592785 endingPage "e060994" @default.
• W4309592785 startingPage "e060994" @default.
• W4309592785 abstract "Objective To estimate continuous positive airway pressure (CPAP) length of treatment effect on survival of hospitalised COVID-19 patients in a medium-sized UK Hospital, and how this effect changes according to the patient’s comorbidity and COVID-19 route of acquisition (community or nosocomial) during the two waves in 2020. Setting The acute inpatient unit in Wrightington, Wigan and Leigh Teaching Hospitals National Health Service (NHS) Foundation Trust (WWL), a medium-sized NHS Trust in north-west of England. Design Retrospective cohort of all confirmed COVID-19 patients admitted in WWL during 2020. Participants 1830 patients (568 first wave, 1262 s wave) with antigen confirmed COVID-19 disease and severe acute respiratory syndrome admitted between 17 March 2020 (first confirmed COVID-19 case) and 31 December 2020. Outcome measure COVID-19 survival rate in all patients and survival rate in potentially hospital-acquired COVID-19 (PHA) patients were modelled using a predictor set which include comorbidities (eg, obesity, diabetes, chronic ischaemic heart disease (IHD), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD)), wave, age, sex and care home residency, and interventions (remdesivir, dexamethasone, CPAP, intensive care unit (ICU), intubation). Secondary outcome measure was CPAP length, which was modelled using the same predictors of the survival rate. Results Mortality rate in the second wave was significantly lower than in the first wave (43.4% vs 28.1%, p<0.001), although for PHA COVID-19 patients mortality did not reduce, remaining at very high levels independently of wave and CPAP length. For all cohort, statistical modelling identified CPAP length (HR 95% CI 0.86 to 0.96) and women (HR 95% CI 0.71 to 0.81) were associated with improved survival, while being older age (HR 95% CI 1.02 to 1.03) admitted from care homes (HR 95% CI 2.22 to 2.39), IHD (HR 95% CI 1.13 to 1.24), CKD (HR 95% CI 1.14 to 1.25), obesity (HR 95% CI 1.18 to 1.28) and COPD-emphysema (HR 95% CI 1.18 to 1.57) were associated with reduced survival. Despite the detrimental effect of comorbidities, patients with CKD (95% CI 16% to 30% improvement in survival), IHD (95% CI 1% to 10% improvement in survival) and asthma (95% CI 8% to 30% improvement in survival) benefitted most from CPAP length, while no significant survival difference was found for obese and patients with diabetes. Conclusions The experience of an Acute Trust during the COVID-19 outbreak of 2020 is documented and indicates the importance of care home and hospitals in disease acquisition. Death rates fell between the first and second wave only for community-acquired COVID-19 patients. The fall was associated to CPAP length, especially for some comorbidities. While uncovering some risk and protective factors of mortality in COVID-19 studies, the study also unravels how little is known about PHA COVID-19 and the interaction between CPAP and some comorbidities." @default.
• W4309592785 created "2022-11-28" @default.
• W4309592785 creator A5030076000 @default.
• W4309592785 creator A5037286630 @default.
• W4309592785 creator A5043368806 @default.
• W4309592785 creator A5058788697 @default.
• W4309592785 creator A5059202910 @default.
• W4309592785 creator A5061922113 @default.
• W4309592785 date "2022-11-01" @default.
• W4309592785 modified "2023-10-14" @default.
• W4309592785 title "Comparison of COVID-19 survival in relation to CPAP length of treatment and by comorbidity and transmission setting (community or hospital acquired) in a medium-sized UK hospital in 2020: a retrospective study" @default.
• W4309592785 cites W1596136668 @default.
• W4309592785 cites W2158196600 @default.
• W4309592785 cites W3014294089 @default.
• W4309592785 cites W3015899127 @default.
• W4309592785 cites W3036252633 @default.
• W4309592785 cites W3039949669 @default.
• W4309592785 cites W3047049020 @default.
• W4309592785 cites W3083985591 @default.
• W4309592785 cites W3092396879 @default.
• W4309592785 cites W3092802064 @default.
• W4309592785 cites W3095283270 @default.
• W4309592785 cites W3097043824 @default.
• W4309592785 cites W3097651475 @default.
• W4309592785 cites W3100530377 @default.
• W4309592785 cites W3103673797 @default.
• W4309592785 cites W3105114552 @default.
• W4309592785 cites W3117250367 @default.
• W4309592785 cites W3121080348 @default.
• W4309592785 cites W3121814242 @default.
• W4309592785 cites W3126157792 @default.
• W4309592785 cites W3126491036 @default.
• W4309592785 cites W3132027664 @default.
• W4309592785 cites W3133514816 @default.
• W4309592785 cites W3138186877 @default.
• W4309592785 cites W3139298974 @default.
• W4309592785 cites W3155716149 @default.
• W4309592785 cites W3155747360 @default.
• W4309592785 cites W3157257196 @default.
• W4309592785 cites W3163672671 @default.
• W4309592785 cites W3164023794 @default.
• W4309592785 cites W3164425374 @default.
• W4309592785 cites W3169878530 @default.
• W4309592785 cites W3184490929 @default.
• W4309592785 cites W3185414941 @default.
• W4309592785 cites W3192688267 @default.
• W4309592785 cites W3192925124 @default.
• W4309592785 cites W3215836628 @default.
• W4309592785 cites W3216768293 @default.
• W4309592785 cites W4200215729 @default.
• W4309592785 cites W4200282447 @default.
• W4309592785 cites W4200288174 @default.
• W4309592785 cites W4205381144 @default.
• W4309592785 cites W4205835050 @default.
• W4309592785 cites W4206519531 @default.
• W4309592785 cites W4207043298 @default.
• W4309592785 cites W4207047636 @default.
• W4309592785 cites W4210427003 @default.
• W4309592785 cites W4210546120 @default.
• W4309592785 cites W4211235253 @default.
• W4309592785 cites W4220830228 @default.
• W4309592785 cites W4224261946 @default.
• W4309592785 cites W4224301487 @default.
• W4309592785 cites W4225522857 @default.
• W4309592785 cites W4249981414 @default.
• W4309592785 cites W4280644267 @default.
• W4309592785 doi "https://doi.org/10.1136/bmjopen-2022-060994" @default.
• W4309592785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36414291" @default.
• W4309592785 hasPublicationYear "2022" @default.
• W4309592785 type Work @default.
• W4309592785 citedByCount "0" @default.
• W4309592785 crossrefType "journal-article" @default.
• W4309592785 hasAuthorship W4309592785A5030076000 @default.
• W4309592785 hasAuthorship W4309592785A5037286630 @default.
• W4309592785 hasAuthorship W4309592785A5043368806 @default.
• W4309592785 hasAuthorship W4309592785A5058788697 @default.
• W4309592785 hasAuthorship W4309592785A5059202910 @default.
• W4309592785 hasAuthorship W4309592785A5061922113 @default.
• W4309592785 hasBestOaLocation W43095927851 @default.
• W4309592785 hasConcept C126322002 @default.
• W4309592785 hasConcept C134018914 @default.
• W4309592785 hasConcept C167135981 @default.
• W4309592785 hasConcept C177713679 @default.
• W4309592785 hasConcept C179755657 @default.
• W4309592785 hasConcept C187212893 @default.
• W4309592785 hasConcept C194828623 @default.
• W4309592785 hasConcept C201903717 @default.
• W4309592785 hasConcept C2776006263 @default.
• W4309592785 hasConcept C2776283816 @default.
• W4309592785 hasConcept C2776376669 @default.
• W4309592785 hasConcept C2776780178 @default.
• W4309592785 hasConcept C2778653478 @default.
• W4309592785 hasConcept C2779159551 @default.
• W4309592785 hasConcept C2779547634 @default.
• W4309592785 hasConcept C555293320 @default.
• W4309592785 hasConcept C71924100 @default.
• W4309592785 hasConcept C72563966 @default.
• W4309592785 hasConceptScore W4309592785C126322002 @default.

• next